New Bacteria-Based Therapy Shows Promise for Fighting Cancer
en-GBde-DEes-ESfr-FR

New Bacteria-Based Therapy Shows Promise for Fighting Cancer


Researchers develop a novel method to enhance the cancer-killing properties of bacteria residing in tumors

Ishikawa, Japan
-- Even as cancer remains a leading cause of death globally, bacteria-based cancer therapy presents an exciting and innovative treatment option. Owing to their ability to penetrate the rigid stromal barrier, bacteria can naturally target solid tumors and offer intratumoural penetration. However, before these bacteria can be used in medical treatments, several important factors need to be addressed. Bacteria intended for clinical trials must be weakened or “attenuated” to ensure their safe use in animals and humans. Additionally, a simple manufacturing procedure is needed to produce safe and effective anticancer bacteria. This calls for the development of an optimal culturing method for bacteria.

Now, in a study published online in the Chemical Engineering Journal, researchers at the Japan Advanced Institute of Science and Technology (JAIST), led by Professor Eijiro Miyako and including Mikako Miyahara, in collaboration with researchers from the University of Tsukuba, Japan, have developed a new method to culture antitumor bacteria using highly porous scaffolds. This innovative approach not only enhanced the anticancer properties of the bacteria but also improved its safety in animal testing.

Previously, the research team isolated a group of bacteria, named A-gyo and UN-gyo from tumors in mice. A-gyo refers to the bacterium Proteus mirabilis and UN-gyo to the photosynthetic bacterium, Rhodopseudomonas palustris. These bacteria inhabit within tumor cells interacting with them, and potentially influencing tumor growth and response to treatment. Together, they form the ‘AUN bacterial consortium’, which shows great promise as a powerful tool for cancer detection because of its ability to effectively target tumors and its safety. However, finding the best way to grow these bacteria was challenging.

To address the challenges of culturing AUN, the researchers explored using specially designed scaffolds. They prepared the microporous scaffold using a biocompatible substance called polydimethylsiloxane (PDMS), combined with titanium dioxide (TiO2). The addition of TiO2 helped create a balance where the bacteria could effectively target tumors but were controlled enough to avoid overly aggressive bacterial growth leading to unintended infections or immune responses. These porous scaffolds significantly boosted the bacteria’s anticancer properties, making them more effective.

Once the researchers prepared the PDMS-TiO2 composite, they cultured AUN bacteria along with blocks of the scaffold while exposing the entire setup to light. They found that when exposed to light, TiO2 in the scaffold effectively attenuated the bacteria by producing toxic molecules called reactive oxygen species (ROS), helping ensure safety during treatment.

Next, they evaluated the anticancer efficacy of AUN. Surprisingly, the researchers found that AUN cultured with the scaffold exhibited an enhanced ability to kill different types of tumor cells. When tested on mice with breast cancer, treatment with the attenuated AUN bacteria led to improved survival rates. Heightened anticancer activity was observed in mice with drug-resistant breast cancer.

We discovered that the strong anticancer response was due to the oncolytic (cancer-killing) properties of AUN itself, with the assistance of various activated immune cells such as T cells, NK cells, and macrophages in the tumor microenvironment,” says Mikako Miyahara, a doctoral student at JAIST and the lead author on the study. The study also confirmed that the AUN cultured with scaffolds could be safely administered not only to mice, but also to dogs.

The improved safety and efficacy of this simple method brings AUN one step closer to its widespread use in cancer treatment, and the authors of the study expect that this technology will be available for clinical trials within the next 10 years.

“Our discovery of how porous scaffolds influence the bacterial activities of AUN will help in designing artificial scaffold material for effective treatment against drug-resistant cancers,” explains Prof. Miyako. In summary, this landmark study lays the groundwork for future commercialization and clinical use of AUN, bringing new hope to patients affected by various types of cancer.


###

Reference
Title of original paper: Photocatalytic scaffolds enhance anticancer performances of bacterial consortium AUN
Authors: Mikako Miyahara, Yuki Doi, Naoki Takaya, Eijiro Miyako*
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2024.156378



About Japan Advanced Institute of Science and Technology, Japan
Founded in 1990 in Ishikawa prefecture, the Japan Advanced Institute of Science and Technology (JAIST) was the first independent national graduate school in Japan. Now, after 30 years of steady progress, JAIST has become one of Japan’s top-ranking universities. JAIST counts with multiple satellite campuses and strives to foster capable leaders with a state-of-the-art education system where diversity is key; about 40% of its alumni are international students. The university has a unique style of graduate education based on a carefully designed coursework-oriented curriculum to ensure that its students have a solid foundation on which to carry out cutting-edge research. JAIST also works closely both with local and overseas communities by promoting industry–academia collaborative research.


About Professor Eijiro Miyako from Japan Advanced Institute of Science and Technology, Japan
Dr. Eijiro Miyako is a Professor at the Materials Chemistry Frontiers Research Area, Japan Advanced Institute of Science and Technology (JAIST). He has been a visiting scientist at Centre National de la Recherche Scientifique (CNRS) (France) and Nanyang Technological University (Singapore). He also served as the Senior Researcher at National Institute of Advanced Industrial Science and Technology (AIST), Japan. His research interests are in the areas of Bioengineering, Materials Chemistry, Nanotechnology, and Nanomedicine. Dr. Miyako received his Ph.D. in Chemical Systems and Engineering from Kyushu University (Japan) in 2006. He has received research prizes and awards such as PCCP Prize in Royal Society of Chemistry and Research Encouragement Award in The Fullerenes, Nanotubes and Graphene Research Society.


Funding information
This work was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (A) (Grant number 23H00551), JSPS KAKENHI Grant-in-Aid for Challenging Research (Pioneering) (Grant number 22K18440), the Japan Science and Technology Agency for Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Grant Number JPMJTR22U1), Institute for Fermentation, Osaka (IFO), and the Uehara Memorial Foundation. M. M. thanks to JST SPRING (Grant number JPMJSP2102).
Title: Photocatalytic scaffolds enhance anticancer performances of bacterial consortium AUN
Authors: Mikako Miyahara, Yuki Doi, Naoki Takaya, Eijiro Miyako*
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2024.156378
Funding information:
This work was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (A) (Grant number 23H00551), JSPS KAKENHI Grant-in-Aid for Challenging Research (Pioneering) (Grant number 22K18440), the Japan Science and Technology Agency for Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Grant Number JPMJTR22U1), Institute for Fermentation, Osaka (IFO), and the Uehara Memorial Foundation. M. M. thanks to JST SPRING (Grant number JPMJSP2102).
Fichiers joints
  • Image Title: Antitumor efficacy of AUN increased using scaffolds.  Image Caption: An illustration showing the anticancer bacterial strains, A-gyo and UN-gyo, along with a simple method for growing AUN using a light-prepared scaffold.  Image Credit: Eijiro Miyako from JAIST.
Regions: Asia, Japan, Singapore, Europe, France
Keywords: Science, Chemistry, Life Sciences, Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement